Literature DB >> 24419338

Resurrecting inactive antimicrobial peptides from the lipopolysaccharide trap.

Harini Mohanram1, Surajit Bhattacharjya.   

Abstract

Host defense antimicrobial peptides (AMPs) are a promising source of antibiotics for the treatment of multiple-drug-resistant pathogens. Lipopolysaccharide (LPS), the major component of the outer leaflet of the outer membrane of Gram-negative bacteria, functions as a permeability barrier against a variety of molecules, including AMPs. Further, LPS or endotoxin is the causative agent of sepsis killing 100,000 people per year in the United States alone. LPS can restrict the activity of AMPs inducing aggregations at the outer membrane, as observed for frog AMPs, temporins, and also in model AMPs. Aggregated AMPs, "trapped" by the outer membrane, are unable to traverse the cell wall, causing their inactivation. In this work, we show that these inactive AMPs can overcome LPS-induced aggregations while conjugated with a short LPS binding β-boomerang peptide motif and become highly bactericidal. The generated hybrid peptides exhibit activity against Gram-negative and Gram-positive bacteria in high-salt conditions and detoxify endotoxin. Structural and biophysical studies establish the mechanism of action of these peptides in LPS outer membrane. Most importantly, this study provides a new concept for the development of a potent broad-spectrum antibiotic with efficient outer membrane disruption as the mode of action.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24419338      PMCID: PMC4023739          DOI: 10.1128/AAC.02321-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  65 in total

1.  Action of antimicrobial peptides: two-state model.

Authors:  H W Huang
Journal:  Biochemistry       Date:  2000-07-25       Impact factor: 3.162

2.  Antimicrobial peptides of multicellular organisms.

Authors:  Michael Zasloff
Journal:  Nature       Date:  2002-01-24       Impact factor: 49.962

Review 3.  From innate immunity to de-novo designed antimicrobial peptides.

Authors:  Yechiel Shai
Journal:  Curr Pharm Des       Date:  2002       Impact factor: 3.116

Review 4.  Epidemiology of sepsis: an update.

Authors:  D C Angus; R S Wax
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

5.  The lipopolysaccharide barrier: correlation of antibiotic susceptibility with antibiotic permeability and fluorescent probe binding kinetics.

Authors:  D S Snyder; T J McIntosh
Journal:  Biochemistry       Date:  2000-09-26       Impact factor: 3.162

6.  Efficacy and safety of recombinant human activated protein C for severe sepsis.

Authors:  G R Bernard; J L Vincent; P F Laterre; S P LaRosa; J F Dhainaut; A Lopez-Rodriguez; J S Steingrub; G E Garber; J D Helterbrand; E W Ely; C J Fisher
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

7.  Single-step, chromogenic Limulus amebocyte lysate assay for endotoxin.

Authors:  G K Lindsay; P F Roslansky; T J Novitsky
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

Review 8.  Innate immunity and the normal microflora.

Authors:  H G Boman
Journal:  Immunol Rev       Date:  2000-02       Impact factor: 12.988

Review 9.  Sepsis syndromes: understanding the role of innate and acquired immunity.

Authors:  A Oberholzer; C Oberholzer; L L Moldawer
Journal:  Shock       Date:  2001-08       Impact factor: 3.454

10.  NMR structure of temporin-1 ta in lipopolysaccharide micelles: mechanistic insight into inactivation by outer membrane.

Authors:  Rathi Saravanan; Mangesh Joshi; Harini Mohanram; Anirban Bhunia; Maria Luisa Mangoni; Surajit Bhattacharjya
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

View more
  25 in total

Review 1.  Latarcins: versatile spider venom peptides.

Authors:  Peter V Dubovskii; Alexander A Vassilevski; Sergey A Kozlov; Alexey V Feofanov; Eugene V Grishin; Roman G Efremov
Journal:  Cell Mol Life Sci       Date:  2015-08-19       Impact factor: 9.261

2.  Ultrashort Antimicrobial Peptides with Antiendotoxin Properties.

Authors:  Ya-Han Chih; Yen-Shan Lin; Bak-Sau Yip; Hsiu-Ju Wei; Hung-Lun Chu; Hui-Yuan Yu; Hsi-Tsung Cheng; Yu-Ting Chou; Jya-Wei Cheng
Journal:  Antimicrob Agents Chemother       Date:  2015-06-01       Impact factor: 5.191

3.  Oligopolyphenylenevinylene-conjugated oligoelectrolyte membrane insertion molecules selectively disrupt cell envelopes of Gram-positive bacteria.

Authors:  Jamie Hinks; Wee Han Poh; Justin Jang Hann Chu; Joachim Say Chye Loo; Guillermo C Bazan; Lynn E Hancock; Stefan Wuertz
Journal:  Appl Environ Microbiol       Date:  2015-01-09       Impact factor: 4.792

Review 4.  Atomic-Resolution Structures and Mode of Action of Clinically Relevant Antimicrobial Peptides.

Authors:  Surajit Bhattacharjya; Sk Abdul Mohid; Anirban Bhunia
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

5.  A Novel RNase 3/ECP Peptide for Pseudomonas aeruginosa Biofilm Eradication That Combines Antimicrobial, Lipopolysaccharide Binding, and Cell-Agglutinating Activities.

Authors:  David Pulido; Guillem Prats-Ejarque; Clara Villalba; Marcel Albacar; Juan J González-López; Marc Torrent; Mohammed Moussaoui; Ester Boix
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

Review 6.  Developments with investigating descriptors for antimicrobial AApeptides and their derivatives.

Authors:  Olapeju Bolarinwa; Jianfeng Cai
Journal:  Expert Opin Drug Discov       Date:  2018-06-22       Impact factor: 6.098

7.  Aggregation and Its Influence on the Bioactivities of a Novel Antimicrobial Peptide, Temporin-PF, and Its Analogues.

Authors:  Yu Zai; Xinping Xi; Zhuming Ye; Chengbang Ma; Mei Zhou; Xiaoling Chen; Shirley W I Siu; Tianbao Chen; Lei Wang; Hang Fai Kwok
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

8.  β-Boomerang Antimicrobial and Antiendotoxic Peptides: Lipidation and Disulfide Bond Effects on Activity and Structure.

Authors:  Harini Mohanram; Surajit Bhattacharjya
Journal:  Pharmaceuticals (Basel)       Date:  2014-04-21

9.  Antifungal Activity of 14-Helical β-Peptides against Planktonic Cells and Biofilms of Candida Species.

Authors:  Namrata Raman; Myung-Ryul Lee; David M Lynn; Sean P Palecek
Journal:  Pharmaceuticals (Basel)       Date:  2015-08-13

10.  The C-terminal Domain Supports a Novel Function for CETPI as a New Plasma Lipopolysaccharide-Binding Protein.

Authors:  Victor García-González; Nadia Gutiérrez-Quintanar; Jaime Mas-Oliva
Journal:  Sci Rep       Date:  2015-11-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.